Edaravone/Taurine | m-entrepreneurship.com

Product Name :
Edaravone/Taurine

Search keywords :
Edaravone

drugId :
null

Target Vo:
Free radicals

Target Vo Short Name :
Free radicals

Moa_Name:
Free radicals scavengers

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Nanjing Yoko Biomedical Co Ltd

Active Company_Name :
Nanjing Yoko Biomedical Co Ltd

Active Indication_Name:
Brain Infarction

In Active Indication_Name:
Nervous System Diseases

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:
Phase 2 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Phospho-AKT (Thr308) Antibody
DNMT1 Antibody (YA781)
p53 Antibody (YA250): p53 Antibody (YA250) is a non-conjugated and Rabbit origined monoclonal antibody about 44 kDa, targeting to p53. It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of Human.

Author: Betaine hydrochloride

Related Posts